Cangrelor CAS No. 163706-36-3 Pharmaceutical Intermediates
overview
Cangrelor is a novel, reversible P2Y12 platelet inhibitor that is administered intravenously. It is specifically designed to provide rapid and effective antiplatelet therapy for patients undergoing PCI.
Unlike traditional oral antiplatelet medications, Cangrelor offers immediate action, making it a critical option in acute care settings.
Its unique mechanism of action allows for quick onset and offset, providing healthcare professionals with the flexibility to manage patients effectively.
Physical and Chemical Properties
- Stability: Stability of Cangrelor under physiological conditions
- pH Range: 4.5 to 7.0
- Storage Conditions: Store at 2°C to 8°C, protected from light.
These properties make Cangrelor an ideal candidate for acute antiplatelet therapy, ensuring that patients receive the most effective treatment with minimal delay.
1. Immediate Platelet Inhibition: Cangrelor achieves peak platelet inhibition within minutes of administration, which is crucial during urgent medical procedures.
2. Reversible Action: The reversible nature of Cangrelor allows for quick recovery of platelet function once the infusion is stopped, reducing the risk of prolonged bleeding.
3. Reduced Risk of Thrombosis: Clinical studies have shown that Cangrelor significantly reduces the risk of thrombotic events in patients undergoing PCI, leading to better patient outcomes.
4. Flexible Dosing: The ability to titrate the dose based on patient response allows for personalized treatment plans, enhancing safety and efficacy.
Cangrelor is designed to integrate seamlessly with a variety of laboratory instruments and consumables. Our company provides a comprehensive range of compatible products, ensuring that healthcare facilities can efficiently utilize Cangrelor in their treatment protocols. This includes:
- Infusion Pumps: For precise delivery of Cangrelor during procedures.
- Monitoring Equipment: To assess platelet function and patient response in real-time.
- Laboratory Consumables: Such as syringes, IV bags, and connectors that meet the highest quality standards.
In conclusion, Cangrelor represents a significant advancement in antiplatelet therapy, offering rapid and effective treatment options for patients in critical care settings.
With its unique physical and chemical properties, Cangrelor provides healthcare professionals with the tools they need to manage patients effectively during PCI and other high-risk procedures. Choose Cangrelor for your antiplatelet therapy needs and experience the difference in patient care.
As a trusted foreign trade company, we are committed to delivering high-quality products and exceptional service to our clients.
For more information about Cangrelor and our range of laboratory products, please contact us today!